Analytical Data
-
Gene name
FLJ14154
- Application
-
Alternative Names
FLJ11693; FLJ14154; HAT4; Histone acetyltransferase type B protein 4; N acetyltransferase 15 (GCN5 related. putative); N alpha acetyltransferase 60; N(alpha) acetyltransferase 60. NatF catalytic subunit; N-acetyltransferase 15; N-alpha-acetyltransferase 60; naa60; NAA60_HUMAN; NAT15; NatF catalytic subunit
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H7X0
-
Expression Region
1-242aa
-
AA Sequence
MTEVVPSSALSEVSLRLLCHDDIDTVKHLCGDWFPIEYPDSWYRDITSNKKFFSLAATYRGAIVGMIVAEIKNRTKIHKEDGDILASNFSVDTQVAYILSLGVVKEFRKHGIGSLLLESLKDHISTTAQDHCKAIYLHVLTTNNTAINFYENRDFKQHHYLPYYYSIRGVLKDGFTYVLYINGGHPPWTILDYIQHLGSALASLSPCSIPHRVYRQAHSLLCSFLPWSGISSKSGIEYSRTM
-
Molecular Weight
53.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FLJ14154 is a recombinant protein that has gained interest in research due to its potential applications in various biomedical fields. Initially identified through cDNA sequencing projects, FLJ14154 is thought to be involved in important cellular processes, yet its specific functions remain largely unexplored. Preliminary studies suggest that it may play a role in cell signaling pathways, given its expression patterns in different tissues, particularly in the brain and immune system. The protein's involvement in these critical physiological processes highlights its importance in understanding disease mechanisms and identifying new therapeutic targets. Moreover, the recombinant form of FLJ14154 enables researchers to investigate its biochemical properties and interactions with other cellular components more effectively. As a subject of ongoing research, FLJ14154 presents opportunities to shed light on its functional roles and to explore its potential implications in disease contexts, including cancer and neurodegenerative disorders. The continued study of this protein could lead to significant advancements in targeting molecular pathways that are pivotal in various diseases, thereby opening new avenues for therapeutic interventions. Therefore, understanding the structure and function of FLJ14154 is crucial for harnessing its potential in clinical applications and furthering our knowledge of cellular biology.
